Forward P/S Multiple: Inari Medical (NARI)

Inari Medical, Inc. - graphic logo of issuer NARI

Does the market confirm the impeccable authority of Inari Medical, Inc. (NARI) in thromboembolism therapy? On the GURU.Markets platform, the forward P/S ratio provides the answer, where 8.10 represents the current level of the metric. Growth is supported by physician training in collaboration with academies and the implementation of non-surgical methodologies. However, for future stability, Inari Medical, Inc. (NARI) must expand its product line to overcome its narrow specialization in thrombectomy.

inarimedical.com - NARI Market Cap to Projected Revenue (period 07/04/2022 - 03/01/2025)

Summary analytical data breakdowns for Inari Medical Corp (NARI)

- market price and analyst price targets:
Price Chart Inari Medical|NARI - Consensus Target
- company stock exchange capitalization indicators:
Market Capitalization Inari Medical Corp|NARI - Total Enterprise Value
- issuer book value statistics:
Book Value per Share Inari Medical|NARI - Accounting Capitalization|Market Capitalization to Book Value Ratio inarimedical.com|NARI - Company Total Asset Base
- debt and liquidity data:
Total Debt to Capital Inari Medical, Inc.|NARI - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Inari Medical, Inc.|NARI - Company Aggregate Debts|Debt to Book Capitalization Ratio Inari Medical Corp|NARI - Company Long-Term Debt|Company Current Liabilities Inari Medical|Quick Ratio inarimedical.com
- financial results and valuation multiples details:
NARI - Company Net Income|Expected Profit Inari Medical, Inc.|NARI - Market Cap to Net Income Ratio|Projected Price to Earnings Inari|NARI - PEG Multiple|EV/EBITDA Multiple Inari Medical Corp|NARI - Operating income before deduction of amortization|Earnings per share for the last twelve months Inari Medical|NARI - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months inarimedical.com|NARI - Net earnings per share growth this year|Earnings growth forecast for next year Inari Medical, Inc.
- sales and revenue indicators:
NARI - Company Total Revenue|Company Projected Revenue Inari Medical|NARI - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple Inari Medical Corp
Fundamental company analysis:NARI (Inari Medical)
Product sample of Inari Medical Corp

To assess the fundamental quality of Inari Medical, Inc. (NARI), it is essential for investors to determine the extent of the premium paid for future growth. This metric measures the multiple of market value to expected revenue for the following year, and the projected price-to-sales ratio helps identify whether valuations are inflated relative to the organic expansion of the medtech product line and the prudent integration of small startups without incurring debt.

Who Inari Medical, Inc. competes with

Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|INSP: Forward P/S Multiple|Market Cap to Projected Revenue PRCT|CNMD (CONMED) - Forward P/S Multiple|Pulse Biosciences Inc (PLSE) - Market Cap to Expected Sales Ratio|Forward P/S Multiple INMD|Forward Price-to-Revenue Multiple Picard Group PMI|Forward P/S Multiple SRDX (Surmodics, Inc.)|Forward P/S Multiple senseonics.com SENS|NPCE - Price-to-Projected Revenue Ratio|TCMD: Price-to-Projected Revenue Ratio|SNWV (SANUWAVE Health, Inc.) - Forward Price-to-Revenue Multiple|Outset Medical Corp - Forward Price to Sales|ELMD (SmartVest) - Forward P/S Multiple|Market Cap to Future Revenue Ratio lensar.com LNSR|Price-to-Projected Revenue Ratio AVITA Medical (RCEL)|profoundmedical.com (PROF) - Projected Price to Revenue|Baird Medical - Forward Price-to-Revenue Multiple|Forward P/S Multiple EDAP TMS SA EDAP|Bovie Medical - Forward P/S Multiple|Market Cap to Expected Sales Ratio IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Price-to-Projected Revenue Ratio|Future Price to Revenue TELA (TELA Bio)|Price-to-Projected Revenue Ratio CytoSorbents Corp|Forward Price-to-Revenue Multiple Sensus (SRTS)|Forward P/S Multiple ZYXI|ECOR - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Vicarious Surgical RBOT|IINN: Market Cap to Projected Revenue|ICU: Forward Price-to-Revenue Multiple|IRIDEX Corporation - Price to Expected Revenue Ratio|INBS: Forward P/S Multiple|XAIR - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio Profusa|Market Cap to Projected Revenue SSKN (STRATA Skin)|Forward P/S Multiple GCTK|Forward P/S Multiple NanoVibronix Inc. (NAOV)|Price-to-Projected Revenue Ratio Venus Concept Inc. VERO|Forward Price to Sales NUWE|Aethlon Medical, Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Asensus Surgical, Inc. ASXC|AVGR (Avinger, Inc) - Forward Price-to-Revenue Multiple|Biosig Technologies - Forward Price to Sales|Price-to-Projected Revenue Ratio Cutera, Inc.|Forward Price-to-Revenue Multiple knowlabs.co (KNW)|Forward P/S Multiple NVRO|RSLS - Market Cap to Future Revenue Ratio|Forward P/S Multiple SILK (Silk Road Medical Inc.)